Barriers and Facilitators in Pricing and Funding Policies of European Countries That Impact the Use of Point-of-Care Diagnostics for Acute Respiratory Tract Infections in Outpatient Practices. Diagnostics (Basel). Read here.

Assessing, Pricing and Funding Point-of-Care Diagnostic Tests for Community-Acquired Acute Respiratory Tract Infections–Overview of Policies Applied in 17 European Countries, Antibiotics. Read here.

Stakeholders’ views and experiences on implementing new diagnostics in primary care to support management of community-acquired acute respiratory tract infections: a qualitative study, Frontiers Public HealthRead here

Usability of OMOP Common Data Model for Detailed Lab Microbiology Results, IOS PressRead here.

Does diagnostic testing always decrease antibiotics prescriptions?, The European Journal of Health EconomicsRead here.

The Opportunity of Point-of-Care Diagnostics in General Practice: Modelling the Effects on Antimicrobial Resistance,  PharmacoEconomicsRead here.

Point of care testing, antibiotic prescribing and prescribing confidence for respiratory tract infections in primary care: Prospective audit in 18 European countries, BJGP OpenRead here.

Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis, Clinical Microbiology and InfectionRead here.

Health‑Economic Analyses of Diagnostics: Guidance on Design and Reporting, Pharmaco Economics. Read here.

Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model, Health Economics Review. Read here.

Primary care for patients with respiratory tract infection before and early on in the COVID-19 pandemic: an observational study in 16 European countries, BMJ Open. Read here.

Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review, Springer NatureRead here.

Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis, Clinical Microbiology and InfectionRead here.

Multi-Criteria Decision Analysis to prioritise hospital admission of patients affected by COVID-19 in settings with hospital-bed shortage, ScienceDirectRead here

Overview of AMR-related resources and services, public report. Read here


Barriers and Facilitators for the Use of Point of Care Diagnostics in Patients With Respiratory Tract Infections in Outpatient Care Related to the Peri-Launch Phase, presented at ISPOR Europe 2023Read here

Fit for Purpose Policy Recommendations Related to Funding, Pricing, and Procurement of Point-of-Care Tests Used in Patients With Respiratory Tract Infections, presented at ISPOR Europe 2023Read here

Analysing Microbiology In Vitro Diagnostics data using the OMOP DCM and SNOMED CT Encoding, presented at SNOMED Expo 2020. Read here

Health-Economics Modelling of Infectious Disease Diagnostics: current approaches and future opportunities, presented at ISPOR Europe 2019 in CopenhagenRead here


Deliverable 5.4: Recommendations for innovative fit for purpose pricing and funding models for CA-ARTI diagnostics. Read here

VALUE-Dx Task 3.4 Modelling report. Read here

HTA, Reimbursement and Pricing of Diagnostic Tests for CA-ARTI – An international overview of policies (Task 5.5). Read here

Interoperable Networks for AMR Laboratory Data – An overarching review of Task 3.4 and federated networking. Read here

OHDSI-OMOP – A proposed standard for AMR data Modelling: Readiness and Recommendations (Task 3.4). Read here

POC 1 Infrastructure documentation (Task 3.4). Read here

EAP executive summary

(full versions available on the login area of the website)

EAP Session 1 – Executive Summary. Read here

EAP Session 2 – Executive Summary. Read here

EAP Session 3 – Executive Summary. Read here

EAP Session 4 – Executive Summary. Read here

EAP Session 5 – Executive Summary. Read here

EAP Session 6 – Executive Summary. Read here

EAP Session 7 – Executive Summary. Read here

Copyright - Value-Dx - Any dissemination of results must indicate that it reflects only the author's view and that the JUis not responsible for any use that may be made of the information it contains.